99 related articles for article (PubMed ID: 11470147)
1. Peripheral blood cell bulk cultures are not suitable for the analysis of the genetic control of T-cell cytokine function.
Zipp F; Windemuth C; Dichgans J; Wienker T; Martin R; Müller C
Immunol Lett; 2001 Aug; 78(1):21-7. PubMed ID: 11470147
[TBL] [Abstract][Full Text] [Related]
2. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.
Zipp F; Windemuth C; Pankow H; Dichgans J; Wienker T; Martin R; Müller C
Hum Immunol; 2000 Oct; 61(10):1021-30. PubMed ID: 11082515
[TBL] [Abstract][Full Text] [Related]
4. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer.
Spurkland A; Celius EG; Knutsen I; Beiske A; Thorsby E; Vartdal F
Tissue Antigens; 1997 Jul; 50(1):15-22. PubMed ID: 9243750
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
7. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis.
Celius EG; Harbo HF; Egeland T; Vartdal F; Vandvik B; Spurkiand A
J Neurol Sci; 2000 Sep; 178(2):132-5. PubMed ID: 11018705
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
9. Presence of a protective allele for achalasia on the central region of the major histocompatibility complex.
de la Concha EG; Fernandez-Arquero M; Conejero L; Lazaro F; Mendoza JL; Sevilla MC; Diaz-Rubio M; Ruiz de Leon A
Tissue Antigens; 2000 Aug; 56(2):149-53. PubMed ID: 11019915
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
Hillert J; Olerup O
Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
[TBL] [Abstract][Full Text] [Related]
11. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis.
Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ
J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622
[TBL] [Abstract][Full Text] [Related]
12. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
13. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children.
Walldén J; Ilonen J; Roivainen M; Ludvigsson J; Vaarala O;
Scand J Immunol; 2008 Sep; 68(3):345-50. PubMed ID: 18782261
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.
Fogdell-Hahn A; Ligers A; Grønning M; Hillert J; Olerup O
Tissue Antigens; 2000 Feb; 55(2):140-8. PubMed ID: 10746785
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR and -DQ genotyping by PCR-SSO in Shanghai Chinese.
Wang FQ; Semana G; Fauchet R; Genetet B
Tissue Antigens; 1993 May; 41(5):223-6. PubMed ID: 8236234
[TBL] [Abstract][Full Text] [Related]
16. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis.
Sandberg-Wollheim M; Ciusani E; Salmaggi A; Pociot F
Mult Scler; 1995 Nov; 1(3):181-5. PubMed ID: 9345451
[TBL] [Abstract][Full Text] [Related]
18. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
20. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
